Patient Conversations: Setting the Stage for Positive Multifocal IOL Outcomes


Educating patients on what they’ll experience before and after cataract surgery gives them the knowledge and confidence to proactively manage their experience and their mindset, driving positive outcomes. Explore the tabs below to learn more.


Streamlining the Multifocal IOL Patient Journey: Customizing Vision

The patient journey is the progression from the initial diagnosis and referral to your practice to cataract surgery and recovery. Proper management of this journey by you and your staff can help ensure your patients are satisfied with the process and with their multifocal IOLs. Click each step in the patient journey graphic below for tips about enhancing your patients’ experience.

Once cataracts have been diagnosed and patients have been referred to your practice, prepare them for their appointment by mailing or emailing them educational materials. Include a welcome letter introducing yourself and your practice, and describe other educational tools available to them.

The pre-op measurement process presents an excellent opportunity for your staff to educate patients on the types of IOLs available to them. It should be patient friendly, promoting a relaxed environment and helping patients make a more informed decision upon your recommendation.

If you decide that the patient is a good multifocal candidate, make a clear recommendation and outline the benefits and limitations of the IOL you’re recommending, setting appropriate expectations.

Designating a member of your staff to discuss the specifics of multifocal lens pricing with patients can relieve pressure on you, allowing you to make a confident recommendation regardless of cost.

After your recommendation, send patients home with educational materials to review. Their lens choice should be reinforced by your staff as part of routine reminders and information given prior to the procedure.

As part of your assessment immediately after surgery, patients should be reminded that visual disturbances, such as halos, glare, flare and blurred near vision, especially in dim light conditions, may occur during the recovery process but will generally subside over time.1

Even if you manage your patients' pre- and post-op expectations well, some patients may still express unhappiness with their initial outcome. Pay extra attention to these patients and show them that you and your practice are dedicated to working toward an optimal outcome.

It is essential to educate patients as early as possible about their IOL options to fully prepare them for what lies ahead in their journey. Keep reading for tips on communicating effectively with multifocal candidates about the benefits and the challenges of this advanced technology.



Instill confidence

If you’re convinced your patient would be well served by multifocal IOLs, you'll be better at making the recommendation. It's a visual acuity upgrade and should be addressed as such. Making a confident recommendation will bolster your patient's confidence.



Visit the interactive vision simulator

Convey specific benefits

For example, tell patients that basic IOLs would only allow them to see clearly at a distance. For tasks like reading, cooking, using a cell phone and other close-up tasks, they’d still need reading glasses after surgery. Let them know that with AcrySof® IQ ReSTOR® Multifocal IOLs, they may be able to do more without their glasses.



Emphasize value

One way to do this is to compare investing in multifocal IOLs to investing in a car: Most people pay thousands of dollars for a vehicle they use for a few minutes or a few hours a day, while they use their vision every waking moment of their life.



Set realistic expectations

Don’t overpromise. Along with the benefits of multifocals, discuss side effects like glare and halos around lights, which are to be expected initially after surgery but should fade away over time as the brain adapts to the new lenses.1



Deliver a consistent message on multifocal IOLs from start to finish

Make sure you and your staff — from the receptionist to the technician — are all delivering a clear, consistent message when it comes to multifocals. If you say one thing and a member of your staff says another, your patients may question their decision.



Provide valuable education resources

To bolster your recommendation, send your patients to FreedomFromCataracts.com for a comprehensive and interactive educational experience on cataracts and other ocular conditions. The website includes:

  • Information on how and why cataracts occur
  • Educational materials on treatment options
  • AcrySof® IQ ReSTOR® Multifocal IOL patient testimonial videos

Dr. Anna Fakadej discusses orchestrating comprehensive patient education throughout the patient’s journey.

Dr. Anna Fakadej discusses orchestrating comprehensive patient education throughout the patient’s journey.
Dr. Anna Fakadej discusses orchestrating comprehensive patient education throughout the patient’s journey.

Watch Dr. Robert J. Cionni demonstrate his technique for confidently recommending multifocal IOLs.

Watch Dr. Robert J. Cionni demonstrate his technique for confidently recommending multifocal IOLs.
Watch Dr. Robert J. Cionni demonstrate his technique for confidently recommending multifocal IOLs.
X
View Important Product Information for
AcrySof® IQ ReSTOR® Family of IOLs +

ACRYSOF® IQ RESTOR® FAMILY OF INTRAOCULAR LENSES IMPORTANT PRODUCT INFORMATION

CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician.

INDICATIONS: The AcrySof® IQ ReSTOR® Posterior Chamber Intraocular Lens (IOL) is intended for primary implantation for the visual correction of aphakia secondary to removal of a cataractous lens in adult patients with and without presbyopia, who desire near, intermediate and distance vision with increased spectacle independence. The lens is intended to be placed in the capsular bag.

WARNINGS/PRECAUTIONS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Physicians should target emmetropia, and ensure that IOL centration is achieved. Care should be taken to remove viscoelastic from the eye at the close of surgery.

Some patients may experience visual disturbances and/or discomfort due to multifocality, especially under dim light conditions. As with other multifocal IOLs, visual symptoms may be significant enough that the patient will request explant of the multifocal IOL. Spectacle independence rates vary with all multifocal IOLs; as such, some patients may need glasses when reading small print or looking at small objects.

Clinical studies with the AcrySof® ReSTOR® lens indicated that posterior capsule opacification (PCO), when present, developed earlier into clinically significant PCO. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure available from Alcon for this product informing them of possible risks and benefits associated with the AcrySof® IQ ReSTOR® IOLs.

Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof® Natural IOL and normal color vision. The effect on vision of the AcrySof® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45° C; use only sterile irrigating solutions such as BSS® or BSS PLUS® Sterile Intraocular Irrigating Solutions.

ATTENTION: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions.

Click here to view the AcrySof® IQ ReSTOR® +2.5 D IOL Directions for Use (DFU).

Click here to view the AcrySof® IQ ReSTOR® +3.0 D IOL Directions for Use (DFU).

ACRYSOF® IQ RESTOR® FAMILY OF INTRAOCULAR LENSES IMPORTANT PRODUCT INFORMATION

CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician.

INDICATIONS: The AcrySof® IQ ReSTOR® Posterior Chamber Intraocular Lens (IOL) is intended for primary implantation for the visual correction of aphakia secondary to removal of a cataractous lens in adult patients with and without presbyopia, who desire near, intermediate and distance vision with increased spectacle independence. The lens is intended to be placed in the capsular bag.

WARNINGS/PRECAUTIONS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Physicians should target emmetropia, and ensure that IOL centration is achieved. Care should be taken to remove viscoelastic from the eye at the close of surgery.

Some patients may experience visual disturbances and/or discomfort due to multifocality, especially under dim light conditions. As with other multifocal IOLs, visual symptoms may be significant enough that the patient will request explant of the multifocal IOL. Spectacle independence rates vary with all multifocal IOLs; as such, some patients may need glasses when reading small print or looking at small objects.

Clinical studies with the AcrySof® ReSTOR® lens indicated that posterior capsule opacification (PCO), when present, developed earlier into clinically significant PCO. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure available from Alcon for this product informing them of possible risks and benefits associated with the AcrySof® IQ ReSTOR® IOLs.

Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof® Natural IOL and normal color vision. The effect on vision of the AcrySof® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45° C; use only sterile irrigating solutions such as BSS® or BSS PLUS® Sterile Intraocular Irrigating Solutions.

ATTENTION: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions.

Click here to view the AcrySof® IQ ReSTOR® +2.5 D IOL Directions for Use (DFU).

Click here to view the AcrySof® IQ ReSTOR® +3.0 D IOL Directions for Use (DFU).